Treating Kaposi's lesions in the HIV-infected patient.
Kaposi's sarcoma is the most frequent malignant neoplasm in AIDS, occurring in about 10 percent of all risk groups. This study evaluates the effect of intralesional vinblastine on intraoral Kaposi's sarcoma in 24 HIV-positive, homosexual males with 82 lesions. Complete resolution occurred in nearly 70 percent of the cases.
Nichols
C M
CM
Dental Branch, University of Texas Health Sciences Center, Houston.
Flaitz
C M
CM
Hicks
M J
MJ
D000328:Adult; D005500:Follow-Up Studies; D015658:HIV Infections / Q000150:complications*; D006716:Homosexuality; D006801:Humans; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000188:drug therapy* / Q000209:etiology; D009364:Neoplasm Recurrence, Local; D012514:Sarcoma, Kaposi / Q000188:drug therapy* / Q000209:etiology; D014747:Vinblastine / Q000008:administration & dosage*
D014747:Vinblastine